Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-18

Clinical Trial Update: Repository Corticotropin Injection To Treat Rheumatoid Arthritis Patients Who Have Failed Three Biologic Therapies. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating repository corticotropin injection for rheumatoid arthritis patients who failed three biologic therapies has completed and p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acthar Gel (repository corticotropin injection)

Snippet

Sponsor: Arthritis Treatment Center, Maryland | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2016-08-18